Introduction: Identifying diabetic neuropathy (DPN) in the clinic is challenging. The purpose of this study is to investigate the utility of various diagnostic tools for the detection of DPN

Methods: The following measures were assessed in controls and patients with type 2 diabetes with and without DPN: clinical neuropathy scores, quantitative sensory testing, corneal confocal microscopy, and sudomotor function. Receiver operating characteristics and areas under the curve with sensitivity and specificity were calculated

Results: See Table and Figure

Conclusions: Functional measures were more sensitive but less specific than structural ones. Similar to other studies, our study shows that no individual test is reliable per-se. Future studies are needed to investigate the best combination of tests for assessing DPN.

graphic
View largeDownload slide
graphic
View largeDownload slide
Disclosure

C.M.Casellini: None. H.Parson: None. C.Cushman: None. A.M.Ingram: None. J.L.Pettaway: None. T.Sears: None. E.S.Siraj: Research Support; Novo Nordisk, Speaker's Bureau; Novo Nordisk, Boehringer Ingelheim and Eli Lilly Alliance.

© 2023 by the American Diabetes Association
2023
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.